News > News Archive

Novartis Stalevo FIRST STEP Study Publication Press Release


Patients with early Parkinson’s disease experienced better symptom control and improvements in daily activities with Stalevo« than carbidopa/levodopa, according to newly-published study.

Go to earlier archived stories